Getting Started with mRNA-based Therapeutics — Myths, Considerations, and Characterization

Available On Demand

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

  Register

Getting Started with mRNA-based Therapeutics — Myths, Considerations, and Characterization

Available On Demand

Already Registered? Click Here

Join the "Getting started with mRNA-based therapeutics" roundtable to explore mRNA challenges, including usability, stability, and technological limits. Gain insights into developmental considerations for clinic-bound constructs. Explore the crucial role of characterizing and analyzing mRNA in the early stages of development.

Key Topics to be Covered:

  • Dispelling myths around mRNA challenges, including usability, stability, and technology limits in mRNA-based therapeutic applications.
  • Insights into mRNA construct development for clinical use and developmental considerations across stages.
  • Importance of mRNA characterization and analysis early in the development process; exploration of analytical methods.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.

Presenters

Presenter
Hannah Ellerbrock
Director RNA Manufacturing
TriLink BioTechnologies
View Biography
Presenter
Ben Hudson, PhD
Associate Director of mRNA Research & Development
TriLink BioTechnologies
View Biography
Presenter
Inna Koukhareva, PhD
Director of Analytical Services
TriLink BioTechnologies
View Biography